Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 400 abstracts

no pagination
Horwitz EM, Hanks GE. External beam radiation therapy for prostate cancer. CA: a cancer journal for clinicians. 2000 Nov;50(6):349-75; quiz 376-9.
Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halberr T, Qian M, Gallo JM. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res. 2000 Aug;6(8):3071-80.
Iczkowski KA, Han AC, Edelson MI, Rosenblum NG. Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case report. J Reprod Med. 2000 Oct;45(10):853-6.
Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, Chen PY, Vicini FA. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000 Jan;46(1):35-43.
Kruger WD. Vitamins and homocysteine metabolism. Vitam Horm. 2000 Jan;60:333-52.
Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Molecular genetics and metabolism. 2000 May;70(1):53-60.
Langer CJ. The role of new agents in advanced non-small-cell lung carcinoma. Current oncology reports. 2000 Jan;2(1):76-89.
Langer CJ. Advanced non-small cell lung carcinoma: the emerging role of docetaxel. Invest New Drugs. 2000 Feb;18(1):17-28.
Langer CJ, McAleer CA, Bonjo CA, Litwin S, Millenson M, Kosierowski R, Blankstein K, Alexander R, Ozols RF. Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC). Eur J Cancer. 2000 Jan;36(2):183-93.
Logginidou H, Ao X, Russo I, Henske EP. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest. 2000 Jan;117(1):25-30.
Ozols RF. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer. Semin Oncol. 2000 Jun;27(3 Suppl 7):3-7.
Ozols RF. The role of gemcitabine in the treatment of ovarian cancer. Semin Oncol. 2000 Feb;27(1 Suppl 2):40-7.
Pendyala L, Creaven PJ, Schwartz G, Meropol NJ, Bolanowska-Higdon W, Zdanowicz J, Murphy M, Perez R. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione. Clin Cancer Res. 2000 Apr;6(4):1314-21.
Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. Gynecol Oncol. 2000 Feb;76(2):204-7.
Schilder RJ, Goldberg M, Millenson MM, Movsas B, Rogatko A, Rogers B, Langer CJ. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer. 2000 Jan;27(1):37-45.
Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol. 2000 Jul;18(14):2780-7.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
Weil SC. Minimal residual disease in acute promyelocytic leukemia. Clin Lab Med. 2000 Mar;20(1):105-17, ix.
Weiner LM, Adams GP. New approaches to antibody therapy. Oncogene. 2000 Dec 11;19(53):6144-51.
Young RC. The sounds of silence. Nature. 2000 Nov 09;408(6809):141.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human Female drug therapy Middle Age Non-US Gov't Support US Gov't Support-PHS Antineoplastic Combined Chemotherapy Protocols Male pathology Aged metabolism Neoplasms therapy analogs & derivatives Adult blood Lung Neoplasms Drug Dose-Response Relationship Paclitaxel Non-Small-Cell Lung Carcinoma Treatment Outcome administration & dosage Deoxycytidine pharmacokinetics adverse effects Antineoplastic Antimetabolites Phytogenic Antineoplastic Agents Homocysteine radiotherapy diagnosis Carboplatin adverse effects genetics Disease-Free Survival Combined Modality Therapy use Mononuclear Leukocytes Biopsy Prognosis Salvage Therapy Retrospective Studies Animal Neoplasm Staging drug effects Survival Rate therapeutic Cisplatin Radiotherapy Dosage Ovarian Neoplasms urine Antineoplastic Agents surgery Adenocarcinoma Drug Administration Schedule epidemiology Squamous Cell Carcinoma pharmacology Pilot Projects biosynthesis X-Ray Computed Tomography Clinical Trials prevention & control methods immunology complications Biological Models Iridium Radioisotopes Progesterone Receptors etiology Enzyme-Linked Immunosorbent Assay Analysis of Variance Neoplasm Antibodies Mesna Algorithms Oral Administration Randomized Controlled Trials Immunoglobulin G Bone Marrow Transplantation Kidney Failure Nutritional Status Haplotypes Kidney Neoplasms CD80 Antigens Multiple Primary Neoplasms US Gov't Support-Non-PHS Cultured Tumor Cells Bilirubin Residual Neoplasm Bispecific Antibodies T-Lymphocytes United States Sulfhydryl Compounds Interferons Promyelocytic Leukemia-Acute Carcinoembryonic Antigen Cadherins Alkylating Antineoplastic Agents CD44 Antigens Estrogen Receptors Translocation (Genetics) Case Report Acetaldehyde Vinblastine Thoracotomy Cysteine Vulvar Neoplasms Quality of Life Polymorphism (Genetics) Phase III Clinical Trials Hematopoietic Stem Cell Mobilization Vitamins Vitamin B 6 Deficiency Risk Factors Immunotherapy Antibodies Polymerase Chain Reaction Conformal Radiotherapy Computer-Assisted Radiotherapy Planning Avipoxvirus Proto-Oncogene Protein p21(ras) Biological Tumor Markers Liver Diseases Aspartate Aminotransferases Vitamin B 12 Deficiency Adjuvant Radiotherapy World Health Antibody-Dependent Cell Cytotoxicity Angiomyolipoma Bridged Compounds Neural Tube Defects Brachytherapy Creatinine 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Cervix Neoplasms Amine Oxidoreductases Regression Analysis Hormonal Antineoplastic Agents Cystathionine beta-Synthase Comparative Study Cohort Studies Liver Function Tests Tamoxifen Colorectal Neoplasms Interferon Type II Vascular Diseases Intravenous Infusions Biological Response Modifiers Oxidation-Reduction
Last updated on Wednesday, March 04, 2020